Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes

OBJECTIVE: Methylglyoxal (MGO), a reactive aldehyde forming advanced glycation end products (AGEs), is increased in diabetes and recognized by the immune system, resulting in anti-AGE–specific autoantibodies. The association of these immune responses with macro- and microvascular complications in ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Sveen, Kari Anne, Bech Holte, Kristine, Svanteson, Mona, Hanssen, Kristian F., Nilsson, Jan, Bengtsson, Eva, Julsrud Berg, Tore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247486/
https://www.ncbi.nlm.nih.gov/pubmed/33858856
http://dx.doi.org/10.2337/dc20-2089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247486/
https://www.ncbi.nlm.nih.gov/pubmed/33858856
http://dx.doi.org/10.2337/dc20-2089

Ejemplares similares